RAPS.org needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site such as personalized content. Please see our Privacy Policy for more information.

RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
11 August 2020
“We would have to be very secure about the safety of a vaccine,” said Hahn. “We would have to see the evidence of clinical efficacy. We’re not going to back away from what we’ve said with respect to these data. We’ve set a floor of 50% for efficacy.”

Latest News

ALL
11 August 2020
The European Commission on Tuesday published the results of a yearslong evaluation of the EU’s orphan and pediatric medicines regulations it says will be used to guide future legislative changes and shape the EU pharmaceutical strategy.
11 August 2020
Welcome to Asia-Pacific Regulatory Roundup, our weekly overview of the top regulatory news from the Asia-Pacific region.
10 August 2020
A new draft guidance from the US Food and Drug Administration (FDA) gives industry direction in how to assess drug-drug interactions for therapeutic proteins.  
10 August 2020
In a new guidance document, the European Commission’s Medical Device Coordination Group (MDCG) details how notified bodies can reference Medical Device Single Audit Program (MDSAP) audit reports when planning surveillance audits under the Medical ...
10 August 2020
The US Food and Drug Administration (FDA) on Monday finalized its guidance on marketing status notifications for new and generic drugs, clarifying its expectations for application holders required to submit marketing status notifications when thei...
07 August 2020
President Donald Trump on Thursday signed an executive order aimed at onshoring the production of essential drugs, medical devices and critical inputs for those products to reduce US reliance on foreign manufacturing and promoting federal procurem...